CITADEL ADVISORS LLC historic quarter change: USA Warrants, Reduced
In warrants (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,717 positions, added to 870, reduced 1,219 and sold out of 1,694.
- Q2 2025: Stock LOCAFY LIMITED; Country of operation —; Class *W EXP 03/29/202; Shares before 46,371.
- Q2 2025: Stock BONE BIOLOGICS CORP; Country of operation —; Class *W EXP 10/13/202; Shares before 35,676.
- Q2 2025: Stock HEARTSCIENCES INC; Country of operation —; Class *W EXP 06/15/202; Shares before 224,809.
- Q2 2025: Stock NEXALIN TECHNOLOGY INC; Country of operation —; Class *W EXP 99/99/999; Shares before 93,133.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2025 | LOCAFY LIMITED
CUSIP Q56120142 | — | *W EXP 03/29/202 | 46,371 | 44,645 | -1,726 | $277,762 | $486,631 | +$208,869 | 2025-08-14 |
|---|
| Q2 2025 | BONE BIOLOGICS CORP
CUSIP 098070154 | — | *W EXP 10/13/202 | 35,676 | 35,673 | -3 | $556,546 | $535,095 | -$21,451 | 2025-08-14 |
|---|
| Q2 2025 | HEARTSCIENCES INC
CUSIP 42254E112 | — | *W EXP 06/15/202 | 224,809 | 223,519 | -1,290 | $11,016 | $20,430 | +$9,414 | 2025-08-14 |
|---|
| Q2 2025 | NEXALIN TECHNOLOGY INC
CUSIP 65345B110 | — | *W EXP 99/99/999 | 93,133 | 90,907 | -2,226 | $16,447 | $7,273 | -$9,174 | 2025-08-14 |
|---|
| Q2 2025 | ROCKET PHARMACEUTICALS INC
CUSIP 77313F114 | — | *W EXP 09/02/202 | 317,303 | 314,842 | -2,461 | $14,913 | $9,067 | -$5,846 | 2025-08-14 |
|---|
| Q2 2025 | GENERATION INCOME PPTYS INC
CUSIP 37149D113 | — | *W EXP 99/99/999 | 26,597 | 25,683 | -914 | $6,383 | $1,418 | -$4,965 | 2025-08-14 |
|---|
| Q2 2025 | APOLLOMICS INC
CUSIP G0411D115 | — | *W EXP 04/01/202 | 239,265 | 158,131 | -81,134 | $2,584 | $7,021 | +$4,437 | 2025-08-14 |
|---|
| Q2 2025 | NUVATION BIO INC
CUSIP 67080N119 | — | *W EXP 02/10/202 | 73,551 | 73,545 | -6 | $23,536 | $19,850 | -$3,686 | 2025-08-14 |
|---|
| Q2 2025 | ABLE VIEW GLOBAL INC
CUSIP G1149B116 | — | *W EXP 08/18/202 | 253,636 | 252,334 | -1,302 | $6,848 | $4,189 | -$2,659 | 2025-08-14 |
|---|
| Q2 2025 | BIOAFFINITY TECHNOLOGIES INC
CUSIP 09076W117 | — | *W EXP 09/07/202 | 35,988 | 32,355 | -3,633 | $6,834 | $4,206 | -$2,628 | 2025-08-14 |
|---|
| Q2 2025 | INNOVATIVE EYEWEAR INC
CUSIP 45791D117 | — | *W EXP 08/16/202 | 43,394 | 22,818 | -20,576 | $3,602 | $1,141 | -$2,461 | 2025-08-14 |
|---|
| Q2 2025 | ALPHA TAU MEDICAL LTD
CUSIP M0740A116 | — | *W EXP 99/99/999 | 40,693 | 33,043 | -7,650 | $9,669 | $7,269 | -$2,400 | 2025-08-14 |
|---|
| Q2 2025 | FOREMOST CLEAN ENERGY LTD
CUSIP 34546R118 | — | *W EXP 08/24/202 | 40,418 | 10,198 | -30,220 | $6,063 | $3,775 | -$2,288 | 2025-08-14 |
|---|
| Q2 2025 | TENON MEDICAL INC
CUSIP 88066N113 | — | *W EXP 06/16/202 | 148,583 | 84,904 | -63,679 | $3,046 | $1,367 | -$1,679 | 2025-08-14 |
|---|
| Q2 2025 | AINOS INC
CUSIP 00902F113 | — | *W EXP 07/29/202 | 36,627 | 17,870 | -18,757 | $4,029 | $2,505 | -$1,524 | 2025-08-14 |
|---|
| Q2 2025 | BENEFICIENT
CUSIP 08178Q119 | United States | *W EXP 06/07/202 | 629,273 | 605,336 | -23,937 | $4,720 | $3,269 | -$1,451 | 2025-08-14 |
|---|
| Q2 2025 | NUTRIBAND INC
CUSIP 67092M125 | — | *W EXP 99/99/999 | 152,715 | 146,834 | -5,881 | $233,654 | $234,934 | +$1,280 | 2025-08-14 |
|---|
| Q2 2025 | SAVERONE 2014 LTD
CUSIP 80516T113 | — | *W EXP 06/02/202 | 63,553 | 62,533 | -1,020 | $1,055 | $2,314 | +$1,259 | 2025-08-14 |
|---|
| Q2 2025 | CONDUIT PHARMACEUTICALS INC
CUSIP 20678X114 | — | *W EXP 09/22/202 | 183,178 | 68,261 | -114,917 | $1,685 | $744 | -$941 | 2025-08-14 |
|---|
| Q2 2025 | SUNSHINE BIOPHARMA INC
CUSIP 867781502 | — | *W EXP 99/99/999 | 30,545 | 20,415 | -10,130 | $6,158 | $5,308 | -$850 | 2025-08-14 |
|---|
| Q2 2025 | AMPLITECH GROUP INC
CUSIP 03211Q119 | — | *W EXP 02/26/202 | 27,467 | 22,816 | -4,651 | $10,987 | $10,267 | -$720 | 2025-08-14 |
|---|
| Q2 2025 | ECD AUTOMOTIVE DESIGN INC
CUSIP 27877D112 | — | *W EXP 12/12/202 | 223,001 | 216,906 | -6,095 | $4,505 | $5,184 | +$679 | 2025-08-14 |
|---|
| Q2 2025 | BT BRANDS INC
CUSIP 0557MQ115 | — | *W EXP 11/12/202 | 23,878 | 10,790 | -13,088 | $984 | $424 | -$560 | 2025-08-14 |
|---|
| Q2 2025 | DRAGONFLY ENERGY HOLDINGS CO
CUSIP 26145B114 | — | *W EXP 10/07/202 | 45,139 | 44,955 | -184 | $1,147 | $593 | -$554 | 2025-08-14 |
|---|
| Q2 2025 | RELIANCE GLOBAL GROUP INC
CUSIP 75946W116 | — | *W EXP 02/01/202 | 40,648 | 40,453 | -195 | $813 | $1,331 | +$518 | 2025-08-14 |
|---|
| Q2 2025 | AMERICAN REBEL HLDGS INC
CUSIP 02919L117 | — | *W EXP 01/20/202 | 37,015 | 23,973 | -13,042 | $415 | $827 | +$412 | 2025-08-14 |
|---|
| Q2 2025 | BOLT PROJS HLDGS INC
CUSIP 09769B115 | — | *W EXP 08/13/202 | 47,767 | 47,667 | -100 | $1,433 | $1,030 | -$403 | 2025-08-14 |
|---|
| Q2 2025 | MOOLEC SCIENCE SA
CUSIP L64875112 | — | *W EXP 12/30/202 | 55,161 | 53,097 | -2,064 | $458 | $796 | +$338 | 2025-08-14 |
|---|
| Q2 2025 | PYXIS TANKERS INC
CUSIP Y71726122 | — | *W EXP 10/13/202 | 22,593 | 20,241 | -2,352 | $897 | $607 | -$290 | 2025-08-14 |
|---|
| Q2 2025 | AUDDIA INC
CUSIP 05072K115 | — | *W EXP 02/19/202 | 76,174 | 74,961 | -1,213 | $1,447 | $1,732 | +$285 | 2025-08-14 |
|---|
| Q2 2025 | MULTISENSOR AI HOLDINGS INC
CUSIP 456948116 | — | *W EXP 12/19/202 | 20,560 | 19,892 | -668 | $827 | $607 | -$220 | 2025-08-14 |
|---|
| Q2 2025 | JEFFS BRANDS LTD
CUSIP M61472110 | — | *W EXP 99/99/999 | 35,304 | 28,293 | -7,011 | $572 | $772 | +$200 | 2025-08-14 |
|---|
| Q2 2025 | 60 DEGREES PHARMACEUTICALS I
CUSIP 83006G112 | — | *W EXP 07/12/202 | 42,422 | 17,668 | -24,754 | $976 | $783 | -$193 | 2025-08-14 |
|---|
| Q2 2025 | XOS INC
CUSIP 98423B116 | — | *W EXP 08/20/202 | 25,943 | 25,813 | -130 | $436 | $245 | -$191 | 2025-08-14 |
|---|
| Q2 2025 | LIXTE BIOTECHNOLOGY HLDGS IN
CUSIP 539319111 | — | *W EXP 11/30/202 | 26,032 | 25,231 | -801 | $880 | $722 | -$158 | 2025-08-14 |
|---|
| Q2 2025 | DISTOKEN ACQUISITION CORP
CUSIP G27740102 | — | *W EXP 11/30/202 | 58,936 | 14,194 | -44,742 | $1,727 | $1,576 | -$151 | 2025-08-14 |
|---|
| Q2 2025 | OSR HLDGS INC
CUSIP 68840D110 | — | *W EXP 02/09/202 | 12,620 | 10,025 | -2,595 | $505 | $647 | +$142 | 2025-08-14 |
|---|
| Q2 2025 | MKDWELL TECH INC
CUSIP G6209W116 | — | *W EXP 07/31/202 | 40,436 | 37,677 | -2,759 | $582 | $441 | -$141 | 2025-08-14 |
|---|
| Q2 2025 | NEWGENIVF GROUP LIMITED
CUSIP G0544E113 | — | *W EXP 04/03/202 | 31,593 | 29,776 | -1,817 | $569 | $694 | +$125 | 2025-08-14 |
|---|
| Q2 2025 | LONGEVITY HEALTH HLDGS INC
CUSIP 142922111 | — | *W EXP 07/12/202 | 45,769 | 44,008 | -1,761 | $1,135 | $1,021 | -$114 | 2025-08-14 |
|---|
| Q2 2025 | XBP EUROPE HOLDINGS INC
CUSIP 98400V119 | — | *W EXP 11/30/202 | 12,166 | 12,066 | -100 | $310 | $410 | +$100 | 2025-08-14 |
|---|
| Q2 2025 | SWVL HOLDINGS CORP
CUSIP G86302117 | — | *W EXP 99/99/999 | 61,881 | 59,416 | -2,465 | $835 | $743 | -$92 | 2025-08-14 |
|---|
| Q2 2025 | CAPTIVISION INC
CUSIP G18932114 | — | *W EXP 11/15/202 | 38,626 | 35,306 | -3,320 | $769 | $847 | +$78 | 2025-08-14 |
|---|
| Q2 2025 | SHF HOLDINGS INC
CUSIP 824430110 | — | *W EXP 09/28/202 | 22,503 | 22,390 | -113 | $563 | $490 | -$73 | 2025-08-14 |
|---|
| Q2 2025 | REVELATION BIOSCIENCES INC
CUSIP 76135L119 | — | *W EXP 01/10/202 | 36,568 | 36,048 | -520 | $366 | $433 | +$67 | 2025-08-14 |
|---|
| Q2 2025 | ALLURION TECHNOLOGIES INC
CUSIP 02008G110 | — | *W EXP 08/01/203 | 14,668 | 11,390 | -3,278 | $425 | $358 | -$67 | 2025-08-14 |
|---|
| Q2 2025 | CHECHE GROUP INC
CUSIP G20707116 | — | *W EXP 10/01/203 | 27,180 | 26,855 | -325 | $742 | $679 | -$63 | 2025-08-14 |
|---|
| Q2 2025 | ECARX HOLDINGS INC
CUSIP G29201111 | — | *W EXP 99/99/999 | 16,031 | 13,142 | -2,889 | $731 | $779 | +$48 | 2025-08-14 |
|---|
| Q2 2025 | MONEYHERO LIMITED
CUSIP G6202B119 | — | *W EXP 09/13/202 | 23,098 | 22,545 | -553 | $818 | $848 | +$30 | 2025-08-14 |
|---|
| Q2 2025 | BANZAI INTERNATIONAL INC
CUSIP 06682J118 | — | *W EXP 12/14/202 | 235,541 | 211,189 | -24,352 | $4,711 | $4,688 | -$23 | 2025-08-14 |
|---|